Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II of Capecitabine and Vinorelbine in Elderly Patients (At Least 65 Years) With Metastatic Breast Cancer With or Without Bone Involvement

NCT00003902 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT00003902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II of Capecitabine and Vinorelbine in Elderly Patients (At Least 65 Years) With Metastatic Breast Cancer With or Without Bone Involvement
Lead sponsor
Swiss Cancer Institute
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 1999
Completion date
September 30, 2005
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer